{"id":"https://openalex.org/W2017981057","doi":"https://doi.org/10.1097/yic.0b013e3283277614","title":"Remission, response without remission, and nonresponse in major depressive disorder: impact on functioning","display_name":"Remission, response without remission, and nonresponse in major depressive disorder: impact on functioning","publication_year":2009,"publication_date":"2009-05-01","ids":{"openalex":"https://openalex.org/W2017981057","doi":"https://doi.org/10.1097/yic.0b013e3283277614","mag":"2017981057","pmid":"https://pubmed.ncbi.nlm.nih.gov/19318972"},"language":"en","primary_location":{"id":"doi:10.1097/yic.0b013e3283277614","doi":"https://doi.org/10.1097/yic.0b013e3283277614","is_oa":false,"landing_page_url":"https://doi.org/10.1097/yic.0b013e3283277614","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081426855","display_name":"Madhukar H. Trivedi","orcid":"https://orcid.org/0000-0002-2983-1110","observed_orcids":["https://orcid.org/0000-0002-2983-1110"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Madhukar H. Trivedi","raw_affiliation_strings":["UT Southwestern Medical Center at Dallas, Texas 75390-9119, USA. Madhukar.Trivedi@UTSouthwestern.edu","UT Southwestern Medical Center at Dallas, Texas","to Dr Madhukar H. Trivedi, MD, Professor of Psychiatry, Betty Jo Hay Distinguished Chair in Mental Health, UT Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, Texas 75390-9119, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UT Southwestern Medical Center at Dallas, Texas 75390-9119, USA. Madhukar.Trivedi@UTSouthwestern.edu","institution_ids":["https://openalex.org/I867280407"]},{"raw_affiliation_string":"UT Southwestern Medical Center at Dallas, Texas","institution_ids":["https://openalex.org/I867280407"]},{"raw_affiliation_string":"to Dr Madhukar H. Trivedi, MD, Professor of Psychiatry, Betty Jo Hay Distinguished Chair in Mental Health, UT Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, Texas 75390-9119, USA","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078730690","display_name":"Patricia K. Corey\u2010Lisle","orcid":"https://orcid.org/0000-0003-2148-6209","observed_orcids":["https://orcid.org/0000-0003-2148-6209"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patricia K. Corey-Lisle","raw_affiliation_strings":["Bristol-Myers Squibb, Wallingford, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Wallingford, Connecticut","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102143945","display_name":"Zhenchao Guo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhenchao Guo","raw_affiliation_strings":["Bristol-Myers Squibb, Wallingford, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Wallingford, Connecticut","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000556882","display_name":"Richard D. Lennox","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard D. Lennox","raw_affiliation_strings":["Psychometric Technologies, Hillsborough, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychometric Technologies, Hillsborough, North Carolina","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Andrei Pikalov","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086062","display_name":"Otsuka (United States)","ror":"https://ror.org/00ew4na22","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210086062"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrei Pikalov","raw_affiliation_strings":["Otsuka America Pharmaceutical Inc., Rockville, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka America Pharmaceutical Inc., Rockville, Maryland","institution_ids":["https://openalex.org/I4210086062"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100728162","display_name":"Edward Kim","orcid":"https://orcid.org/0000-0001-8247-6675","observed_orcids":["https://orcid.org/0000-0001-8247-6675"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward Kim","raw_affiliation_strings":["Bristol-Myers Squibb, Plainsboro, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Plainsboro, New Jersey, USA","institution_ids":["https://openalex.org/I4210091812"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5081426855"],"corresponding_institution_ids":["https://openalex.org/I867280407"],"apc_list":null,"apc_paid":null,"fwci":5.0295,"has_fulltext":false,"cited_by_count":110,"citation_normalized_percentile":{"value":0.95440073,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"24","issue":"3","first_page":"133","last_page":"138"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10214","display_name":"Psychotherapy Techniques and Applications","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":1.0},{"id":"https://openalex.org/keywords/remission","display_name":"remission","score":0.765999972820282},{"id":"https://openalex.org/keywords/nonresponse","display_name":"nonresponse","score":0.7820000052452087},{"id":"https://openalex.org/keywords/functional-disability","display_name":"functional disability","score":0.8519999980926514},{"id":"https://openalex.org/keywords/aripiprazole","display_name":"aripiprazole","score":0.7540000081062317},{"id":"https://openalex.org/keywords/antidepressant-augmentation","display_name":"antidepressant augmentation","score":0.5419999957084656},{"id":"https://openalex.org/keywords/sheehan-disability-scale","display_name":"Sheehan Disability Scale","score":0.847000002861023},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.49000000953674316},{"id":"https://openalex.org/keywords/structural-equation-modeling","display_name":"structural equation modeling","score":0.5070000290870667}],"concepts":[{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.7331025004386902},{"id":"https://openalex.org/C2779583969","wikidata":"https://www.wikidata.org/wiki/Q423757","display_name":"Escitalopram","level":4,"score":0.680536150932312},{"id":"https://openalex.org/C2776466505","wikidata":"https://www.wikidata.org/wiki/Q385555","display_name":"Hamilton Rating Scale for Depression","level":4,"score":0.6241366863250732},{"id":"https://openalex.org/C2777669559","wikidata":"https://www.wikidata.org/wiki/Q407617","display_name":"Sertraline","level":4,"score":0.5923202633857727},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5839637517929077},{"id":"https://openalex.org/C83849319","wikidata":"https://www.wikidata.org/wiki/Q7295720","display_name":"Rating scale","level":2,"score":0.5633038282394409},{"id":"https://openalex.org/C2780211496","wikidata":"https://www.wikidata.org/wiki/Q411188","display_name":"Aripiprazole","level":3,"score":0.5424919128417969},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5289444923400879},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.5156446695327759},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.509096086025238},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.498676061630249},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.4554538130760193},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.41954949498176575},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4107682704925537},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.30059999227523804},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.2881737947463989},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.14802685379981995},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.09138581156730652},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C138496976","wikidata":"https://www.wikidata.org/wiki/Q175002","display_name":"Developmental psychology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068180","descriptor_name":"Aripiprazole","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000465","descriptor_name":"Algorithms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003627","descriptor_name":"Data Interpretation, Statistical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D004185","descriptor_name":"Disability Evaluation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012959","descriptor_name":"Socioeconomic Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015233","descriptor_name":"Models, Statistical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017211","descriptor_name":"Treatment Failure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/yic.0b013e3283277614","doi":"https://doi.org/10.1097/yic.0b013e3283277614","is_oa":false,"landing_page_url":"https://doi.org/10.1097/yic.0b013e3283277614","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:19318972","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19318972","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International clinical psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W1537847405","https://openalex.org/W1967377279","https://openalex.org/W1985193354","https://openalex.org/W1989632226","https://openalex.org/W2007880575","https://openalex.org/W2014629518","https://openalex.org/W2017585287","https://openalex.org/W2020739757","https://openalex.org/W2037920994","https://openalex.org/W2054247262","https://openalex.org/W2069947542","https://openalex.org/W2070828096","https://openalex.org/W2078790138","https://openalex.org/W2085758661","https://openalex.org/W2088302707","https://openalex.org/W2088736589","https://openalex.org/W2091451566","https://openalex.org/W2114057004","https://openalex.org/W2114613490","https://openalex.org/W2132324173","https://openalex.org/W2144864221","https://openalex.org/W2149402043","https://openalex.org/W2156161224","https://openalex.org/W2167845443","https://openalex.org/W2170435962","https://openalex.org/W2173657221"],"related_works":["https://openalex.org/W2589332596","https://openalex.org/W2319580734","https://openalex.org/W3024498130","https://openalex.org/W2327666782","https://openalex.org/W2025491005","https://openalex.org/W194002676","https://openalex.org/W2766521428","https://openalex.org/W2005584135","https://openalex.org/W1996889266","https://openalex.org/W2783415269"],"abstract_inverted_index":{"Major":[0],"depressive":[1],"disorder":[2],"(MDD)":[3],"is":[4],"associated":[5],"with":[6,30,49,67,94,97,106,110,119,163,190,237],"significant":[7],"functional":[8,204],"impairment.":[9],"This":[10],"post-hoc":[11],"analysis":[12],"of":[13,22,45,64,76],"data":[14],"from":[15,218],"two":[16],"randomized":[17,60],"trials":[18],"assessed":[19,118],"the":[20,74,120,125,146],"impact":[21],"response":[23,41,99,135,165],"status":[24,116],"on":[25,223],"functioning":[26,191,231],"in":[27,83,87,104,130,145,157,159,192],"MDD.":[28],"Patients":[29],"at":[31],"least":[32],"one":[33],"historical":[34],"treatment":[35,48,66],"failure":[36],"followed":[37],"by":[38],"an":[39],"inadequate":[40],"after":[42],"8":[43],"weeks":[44,63],"prospective":[46],"open-label":[47],"escitalopram,":[50],"fluoxetine,":[51],"paroxetine-CR,":[52],"sertraline,":[53],"or":[54,70,109],"venlafaxine-XR":[55],"plus":[56],"single-blind":[57],"placebo":[58,69],"were":[59,80,129,154],"to":[61],"6":[62],"double-blind":[65,77],"adjunctive":[68,71],"aripiprazole.":[72],"At":[73],"end":[75],"treatment,":[78],"patients":[79,158,198,238],"defined":[81],"as:":[82],"remission":[84,101,160,167,201,226],"[>or=50%":[85],"reduction":[86,103],"Montgomery-Asberg":[88],"Depression":[89,184],"Rating":[90,181],"Scale":[91,149,182],"(MADRS)":[92],"score":[93],"MADRS":[95,105,107],"<or=10];":[96],"a":[98,111,134,141,164,214],"without":[100,136,166,209],"(>or=50%":[102],">10);":[108],"nonresponse":[112,172],"(all":[113],"others).":[114],"Functional":[115],"was":[117],"Sheehan":[121,147],"Disability":[122,148],"Scale.":[123],"Of":[124],"679":[126],"patients,":[127],"144":[128],"remission,":[131,137],"44":[132],"had":[133,140],"and":[138,151,233],"491":[139],"nonresponse.":[142],"Mean":[143],"improvements":[144,205],"total":[150],"item":[152],"scores":[153],"significantly":[155,188],"greater":[156,203],"versus":[161],"those":[162,207],"(P<0.02)":[168],"as":[169,171],"well":[170],"(P<0.001).":[173],"Structural":[174],"Equation":[175],"Modeling":[176],"found":[177],"that":[178,235],"efficacy":[179],"(Hamilton":[180],"for":[183],"scores)":[185],"did":[186],"not":[187],"correlate":[189],"this":[193],"study.":[194],"In":[195],"conclusion,":[196],"MDD":[197],"achieving":[199],"symptomatic":[200],"experience":[202],"than":[206],"respond":[208],"remission.":[210],"Functioning":[211],"may":[212,228],"be":[213],"distinctly":[215],"different":[216],"outcome":[217],"symptom":[219],"reduction.":[220],"Treatments":[221],"focused":[222],"producing":[224],"high":[225],"rates":[227],"improve":[229],"patient":[230],"over":[232],"above":[234],"seen":[236],"who":[239],"only":[240],"achieve":[241],"response.":[242]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":12},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}